The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery

European Journal of Surgical Oncology

Volumn 43, Issue 4, 2017, Pages 717-724

  Rutten, I J G ^a,b   Ubachs, J ^a   Kruitwagen, R F P M ^a,b   van Dijk, D P J ^a,b   Beets Tan, R G H ^a,b,c   Massuger, L F A G ^d   Olde Damink, S W M ^a,b   Van Gorp, T ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ovarian neoplasms; Postoperative complications; Prognosis; Sarcopenia; Survival; X ray computed tomography

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIMARY DEBULKING SURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOPENIA; SKELETAL MUSCLE; SURFACE AREA; THIRD LUMBAR VERTEBRA; ADIPOSE TISSUE; DIAGNOSTIC IMAGING; INTRAABDOMINAL FAT; KAPLAN MEIER METHOD; MIDDLE AGED; OPERATIVE BLOOD LOSS; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODEL; PSOAS MUSCLE; SUBCUTANEOUS FAT; SURVIVAL RATE; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUSCLE, SKELETAL; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PSOAS MUSCLES; RETROSPECTIVE STUDIES; SARCOPENIA; SUBCUTANEOUS FAT; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 85011025967     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2016.12.016     Document Type: Article

References (29)

1. 1 Torre, L.A., Bray, F., Siegel, R.L., et al. Global cancer statistics, 2012. CA Cancer J Clin 65 (2015), 87–108.
2. 2 Baldwin, L.A., Huang, B., Miller, R.W., et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol 120 (2012), 612–618.
3. 3 Vergote, I., Trope, C.G., Amant, F., et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363 (2010), 943–953.
4. 4 du Bois, A., Reuss, A., Pujade-Lauraine, E., et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 115 (2009), 1234–1244.
5. 5 Tisdale, M.J., Cachexia in cancer patients. Nat Rev Cancer 2 (2002), 862–871.
6. 6 Fearon, K., Strasser, F., Anker, S.D., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12 (2011), 489–495.
7. 7 Shen, W., Punyanitya, M., Wang, Z., et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 80 (2004), 271–278.
8. 8 Shen, W., Punyanitya, M., Wang, Z., et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Phys 97 (2004), 2333–2338.
9. 9 Mourtzakis, M., Prado, C.M., Lieffers, J.R., et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33 (2008), 997–1006.
10. 10 van Vledder, M.G., Levolger, S., Ayez, N., et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99 (2012), 550–557.
11. 11 Psutka, S.P., Boorjian, S.A., Moynagh, M.R., et al. Decreased skeletal muscle mass is associated with an increased risk of mortality after radical nephrectomy for localized renal cell cancer. J Urol 195 (2016), 270–276.
12. 12 Martin, L., Birdsell, L., Macdonald, N., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31 (2013), 1539–1547.
13. 13 Shachar, S.S., Williams, G.R., Muss, H.B., et al. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer 57 (2016), 58–67.
14. 14 Rutten, I.J.G., Van Dijk, D.P.J., Kruitwagen, R.F.P.M., et al. Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle 7:4 (2016 Sep), 458–466.
15. 15 Torres, M.L., Hartmann, L.C., Cliby, W.A., et al. Nutritional status, CT body composition measures and survival in ovarian cancer. Gynecol Oncol 129 (2013), 548–553.
16. 16 Aust, S., Knogler, T., Pils, D., et al. Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer. PLoS One, 10, 2015, e0140403.
17. 17 Lieffers, J.R., Bathe, O.F., Fassbender, K., et al. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107 (2012), 931–936.
18. 18 Fukuda, Y., Yamamoto, K., Hirao, M., et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer 19:3 (2016 Jul), 986–993.
19. 19 Rondanelli, M., Klersy, C., Terracol, G., et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr 103 (2016), 830–840.
20. 20 Gould, D.W., Lahart, I., Carmichael, A.R., et al. Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle 4 (2013), 111–124.
21. 21 Maddocks, M., Murton, A.J., Wilcock, A., Therapeutic exercise in cancer cachexia. Crit Rev Oncog 17 (2012), 285–292.
22. 22 Bowen, T.S., Schuler, G., Adams, V., Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 6 (2015), 197–207.
23. 23 Dindo, D., Demartines, N., Clavien, P.A., Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004), 205–213.
24. 24 Williams, B.A., Mandrekar, J.N., Mandrekar, S.J., et al. Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. Technical Report Series #79., 2006, Mayo Foundation, 1–26.
25. 25 Jones, A. Jr., Shen, W., St-Onge, M.P., et al. Body-composition differences between African American and white women: relation to resting energy requirements. Am J Clin Nutr 79 (2004), 780–786.
26. 26 Tan, L.J., Liu, S.L., Lei, S.F., et al. Molecular genetic studies of gene identification for sarcopenia. Hum Genet 131 (2012), 1–31.
27. 27 Psutka, S.P., Carrasco, A., Schmit, G.D., et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer 120 (2014), 2910–2918.
28. 28 Prado, C.M., Lieffers, J.R., McCargar, L.J., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9 (2008), 629–635.
29. 29 Vergote, I., du Bois, A., Amant, F., et al. Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree?. Gynecol Oncol 128 (2013), 6–11.